Open Access Case report

Six years survival on imatinib with no disease progression after diagnosis of metastatic duodenal gastrointestinal stromal tumour: A case report

Sayantan Bhattacharya1*, Amit K Choudhury2, Srinivasan Ravi2, John Morrissey3 and George Mathew1

1 Department of General Surgery, George Eliot Hospital, College Street, Nuneaton, Warwickshire CV10 7DJ, UK

2 Department of General Surgery, Victoria Hospital, Whinney Heys Road, Blackpool, Lancashire FY3 8NR, UK

3 Institute of Clinical Sciences, Warwick Medical School, Coventry CV4 7AL, UK

For all author emails, please log on.

Journal of Medical Case Reports 2008, 2:110 doi:10.1186/1752-1947-2-110

Published: 18 April 2008

Additional files

Additional file 1:

WHO scale for assessing the performance status of the patient. The table describes the WHO performance status in patients.

Format: JPEG Size: 48KB Download file

Open Data

Additional file 2:

NICE guidelines on Imatinib therapy in GIST. The table describes the NICE guidelines for using Imatinib mesylate in GIST patients.

Format: JPEG Size: 78KB Download file

Open Data